Drug Discovery
- Categories:Company News
- Time of issue:2018-06-07
- Views:0
(Summary description)The four types of generic drugs “Yiyi Maibu” tablets developed by our company received the drug clinical trial approval in November 2016.
Drug Discovery
(Summary description)The four types of generic drugs “Yiyi Maibu” tablets developed by our company received the drug clinical trial approval in November 2016.
- Categories:Company News
- Time of issue:2018-06-07
- Views:0
Information
The four types of generic drugs “Yiyi Maibu” tablets developed by our company received the drug clinical trial approval in November 2016.
The four generic drugs "Pitavastatin Calcium" tablets developed by our company received the clinical trial approval for drugs in October 2016.
The four types of generic drug “capecitabine” tablets developed by our company received the clinical trial approval for drugs in September 2016.
The three generic drugs "wortidine hydrochloride hydrobromide" developed by our company received the clinical trial approval for drugs in August 2016.
The three types of generic drugs "toluene tartrate" tablets developed by our company were approved for clinical trials in August 2016.
The four generic drugs “lenalidomide” capsules developed by our company received the drug clinical trial approval in April 2016.
The three types of generic “Avavira” tablets developed by our company received the approval of the drug clinical trial in March 2016.
The three generic drugs “Topsta” tablets developed by our company received the approval of the drug clinical trial in March 2016.
The three generic drugs “almotriptan malate” developed by our company received the approval of the drug clinical trial in February 2016.
The three types of generic drug "Ulistat acetate" tablets developed by our company received the clinical trial approval for drugs in January 2016.
The four generic drugs “erlotinib HCl” tablets developed by our company received the clinical trial approval for drugs in January 2016.
The three generic drugs "Verazosone Hydrochloride" tablets developed by our company received the clinical trial approval for drugs in January 2016.
The four types of generic drug "Anlishengtan" tablets developed by our company received the approval of the drug clinical trial in January 2016.
Keyword:
Scan the QR code to read on your phone
Previous:
Exhibition
Beijing Hope Pharmaceutical Co., Ltd. 京ICP备17065299号
